[Graves' ophthalmopathy--a prospective clinical study].

Area of Science:

• Endocrinology and Immunology
• Ophthalmology

Context:

• Graves' disease is a progressive autoimmune disorder with variable clinical manifestations.
• Thyroid ophthalmopathy (dysthyroid ophthalmopathy) affects 10-25% of Graves' disease patients.
• Ocular changes can occur before, during, or after the diagnosis of Graves' disease.

Purpose:

• To describe the occurrence and characteristics of thyroid ophthalmopathy in patients with Graves' disease.
• To highlight that dysthyroid ophthalmopathy can manifest independently of thyroid dysfunction.

Summary:

• Dysthyroid ophthalmopathy is a common complication of Graves' disease, characterized by ocular modifications.
• In a significant percentage of cases (10-25%), thyroid ophthalmopathy develops without clinical or biochemical signs of thyroid dysfunction.
• Proptosis is a frequent symptom, observed in 85% of affected individuals, predominantly bilateral.

Impact:

• Emphasizes the importance of considering eye complications in all Graves' disease patients, regardless of thyroid status.
• Informs clinical suspicion for dysthyroid ophthalmopathy even in the absence of overt thyroid dysfunction.
• Highlights the high prevalence of proptosis in dysthyroid ophthalmopathy, aiding in diagnosis and management.